ARPA-H is unlike any other federal research funding agency, backing bold health ideas with the potential to revolutionize healthcare. Each program has three to five years to prove the impossible. Early efforts are already showing results: the NITRO program is on the cusp of making joints heal themselves; ADVOCATE is building what could become the first FDA-authorized AI system to support cardiovascular care; and PROSPR is funding the first real trials testing whether aging can be treated, not just the diseases associated with it. With global competition in biotech intensifying and the Administration betting big on speed over incrementalism, Chief Medical Officer, Rafid Fadul, breaks down what's working, what's next, and how to become a Program Manager who leads the next breakthrough.